![hydration effects glp-1 medications weight loss 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of high protein Option:1 Month Supply Metabolism Method Bundle](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1050961973852737)
![hydration effects glp-1 medications weight loss 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of high protein Option:1 Month Supply Metabolism Method Bundle](https://www.thegentleplate.com/wp-content/uploads/2026/04/GLP-1-Fatigue-Foods-for-Steady-Energy.webp)
![hydration effects glp-1 medications weight loss 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of high protein Option:1 Month Supply Metabolism Method Bundle](https://cdn.prod.website-files.com/642365ffb6788639298dd2ce/685ed6e750b97473ed54f9b2_Vile.png)
![hydration effects glp-1 medications weight loss 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of high protein Option:1 Month Supply Metabolism Method Bundle](https://i5.walmartimages.com/asr/754f4269-8cc7-4e52-b931-705edd401799.a7f95ec88efc947451cf6ad8230cc525.jpeg?odnHeight=768&odnWidth=768&odnBg=FFFFFF)
Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
hydration effects glp-1 medications weight loss 2025 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of high protein Option:1 Month Supply Metabolism Method Bundle
Metabolism Method Bundle
The boxed warning on Wegovy, Ozempic, Zepbound, and Mounjaro is for medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
high protein
Option:1 Month Supply
No awkward clinic visits
